Neurochemical profile of patients with type 1 diabetes measured by 1H-MRS at 4 T

Silvia Mangia, Anjali F. Kumar, Amir Moheet, Rachel J. Roberts, Lynn E Eberly, Elizabeth R Seaquist, Ivan Tkac

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The impact of type 1 diabetes mellitus (T1DM) on a comprehensive neurochemical profile of the human brain has not been reported yet. Our previous proton magnetic resonance spectroscopy (1 H-MRS) studies on T1DM were focused exclusively on the assessment of brain glucose levels. In this study, we reexamined our previously acquired data to investigate concentration differences of a broad range of neurochemicals in T1DM subjects relative to nondiabetic controls. We selected MRS data from 13 subjects (4 F/9 M, age=41±11 years, body mass index=26±3 kg/m 2) with well-controlled T1DM (disease duration=22±12 years, A1C=7.5%±2.0%) and 32 nondiabetic controls (14 F/18 M, age=36±10 years, body mass index=27±6 kg/m 2) acquired during a hyperglycemic clamp (target Glc plasma =300±15 mg/dL). The 1 H-MR spectra were collected from two 15.6-mL voxels localized in gray-matter-rich occipital lobe and in white-matter-rich parieto-occipital region using ultra-short echo-time STEAM at 4 T. LCModel analysis allowed reliable quantification of 17 brain metabolites. Lower levels of N-acetylaspartate (by 6%, P=0.007) and glutamate (by 6%, P=0.045) were observed in the gray matter of T1DM patients as compared with controls, which might indicate a partial neuronal loss or dysfunction as a consequence of long-term T1DM. No other differences in metabolites were observed between subjects with T1DM and controls.

Original languageEnglish (US)
Pages (from-to)754-759
Number of pages6
JournalJournal of Cerebral Blood Flow and Metabolism
Volume33
Issue number5
DOIs
StatePublished - May 1 2013

Fingerprint

Type 1 Diabetes Mellitus
Occipital Lobe
Brain
Body Mass Index
Proton Magnetic Resonance Spectroscopy
Glutamic Acid
Glucose

Keywords

  • MR spectroscopy
  • diabetes
  • glutamate
  • neurochemistry
  • neurotransmitters

Cite this

Neurochemical profile of patients with type 1 diabetes measured by 1H-MRS at 4 T. / Mangia, Silvia; Kumar, Anjali F.; Moheet, Amir; Roberts, Rachel J.; Eberly, Lynn E; Seaquist, Elizabeth R; Tkac, Ivan.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 33, No. 5, 01.05.2013, p. 754-759.

Research output: Contribution to journalArticle

@article{4e5f59b95e434e48a7b948490d486b9d,
title = "Neurochemical profile of patients with type 1 diabetes measured by 1H-MRS at 4 T",
abstract = "The impact of type 1 diabetes mellitus (T1DM) on a comprehensive neurochemical profile of the human brain has not been reported yet. Our previous proton magnetic resonance spectroscopy (1 H-MRS) studies on T1DM were focused exclusively on the assessment of brain glucose levels. In this study, we reexamined our previously acquired data to investigate concentration differences of a broad range of neurochemicals in T1DM subjects relative to nondiabetic controls. We selected MRS data from 13 subjects (4 F/9 M, age=41±11 years, body mass index=26±3 kg/m 2) with well-controlled T1DM (disease duration=22±12 years, A1C=7.5{\%}±2.0{\%}) and 32 nondiabetic controls (14 F/18 M, age=36±10 years, body mass index=27±6 kg/m 2) acquired during a hyperglycemic clamp (target Glc plasma =300±15 mg/dL). The 1 H-MR spectra were collected from two 15.6-mL voxels localized in gray-matter-rich occipital lobe and in white-matter-rich parieto-occipital region using ultra-short echo-time STEAM at 4 T. LCModel analysis allowed reliable quantification of 17 brain metabolites. Lower levels of N-acetylaspartate (by 6{\%}, P=0.007) and glutamate (by 6{\%}, P=0.045) were observed in the gray matter of T1DM patients as compared with controls, which might indicate a partial neuronal loss or dysfunction as a consequence of long-term T1DM. No other differences in metabolites were observed between subjects with T1DM and controls.",
keywords = "MR spectroscopy, diabetes, glutamate, neurochemistry, neurotransmitters",
author = "Silvia Mangia and Kumar, {Anjali F.} and Amir Moheet and Roberts, {Rachel J.} and Eberly, {Lynn E} and Seaquist, {Elizabeth R} and Ivan Tkac",
year = "2013",
month = "5",
day = "1",
doi = "10.1038/jcbfm.2013.13",
language = "English (US)",
volume = "33",
pages = "754--759",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Neurochemical profile of patients with type 1 diabetes measured by 1H-MRS at 4 T

AU - Mangia, Silvia

AU - Kumar, Anjali F.

AU - Moheet, Amir

AU - Roberts, Rachel J.

AU - Eberly, Lynn E

AU - Seaquist, Elizabeth R

AU - Tkac, Ivan

PY - 2013/5/1

Y1 - 2013/5/1

N2 - The impact of type 1 diabetes mellitus (T1DM) on a comprehensive neurochemical profile of the human brain has not been reported yet. Our previous proton magnetic resonance spectroscopy (1 H-MRS) studies on T1DM were focused exclusively on the assessment of brain glucose levels. In this study, we reexamined our previously acquired data to investigate concentration differences of a broad range of neurochemicals in T1DM subjects relative to nondiabetic controls. We selected MRS data from 13 subjects (4 F/9 M, age=41±11 years, body mass index=26±3 kg/m 2) with well-controlled T1DM (disease duration=22±12 years, A1C=7.5%±2.0%) and 32 nondiabetic controls (14 F/18 M, age=36±10 years, body mass index=27±6 kg/m 2) acquired during a hyperglycemic clamp (target Glc plasma =300±15 mg/dL). The 1 H-MR spectra were collected from two 15.6-mL voxels localized in gray-matter-rich occipital lobe and in white-matter-rich parieto-occipital region using ultra-short echo-time STEAM at 4 T. LCModel analysis allowed reliable quantification of 17 brain metabolites. Lower levels of N-acetylaspartate (by 6%, P=0.007) and glutamate (by 6%, P=0.045) were observed in the gray matter of T1DM patients as compared with controls, which might indicate a partial neuronal loss or dysfunction as a consequence of long-term T1DM. No other differences in metabolites were observed between subjects with T1DM and controls.

AB - The impact of type 1 diabetes mellitus (T1DM) on a comprehensive neurochemical profile of the human brain has not been reported yet. Our previous proton magnetic resonance spectroscopy (1 H-MRS) studies on T1DM were focused exclusively on the assessment of brain glucose levels. In this study, we reexamined our previously acquired data to investigate concentration differences of a broad range of neurochemicals in T1DM subjects relative to nondiabetic controls. We selected MRS data from 13 subjects (4 F/9 M, age=41±11 years, body mass index=26±3 kg/m 2) with well-controlled T1DM (disease duration=22±12 years, A1C=7.5%±2.0%) and 32 nondiabetic controls (14 F/18 M, age=36±10 years, body mass index=27±6 kg/m 2) acquired during a hyperglycemic clamp (target Glc plasma =300±15 mg/dL). The 1 H-MR spectra were collected from two 15.6-mL voxels localized in gray-matter-rich occipital lobe and in white-matter-rich parieto-occipital region using ultra-short echo-time STEAM at 4 T. LCModel analysis allowed reliable quantification of 17 brain metabolites. Lower levels of N-acetylaspartate (by 6%, P=0.007) and glutamate (by 6%, P=0.045) were observed in the gray matter of T1DM patients as compared with controls, which might indicate a partial neuronal loss or dysfunction as a consequence of long-term T1DM. No other differences in metabolites were observed between subjects with T1DM and controls.

KW - MR spectroscopy

KW - diabetes

KW - glutamate

KW - neurochemistry

KW - neurotransmitters

UR - http://www.scopus.com/inward/record.url?scp=84877581171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877581171&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2013.13

DO - 10.1038/jcbfm.2013.13

M3 - Article

C2 - 23403373

AN - SCOPUS:84877581171

VL - 33

SP - 754

EP - 759

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 5

ER -